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Abstract
Introduction: In recent years, with the increasing prevalence of allergic rhinitis (AR), a higher incidence of nonal-
lergic rhinitis (NAR) has been observed. 
Aim: The aim of the study was the comparison of pulmonary function tests and the degree of bronchial hyperre-
sponsiveness (BHR) in children with AR and NAR, evaluation of the biomarker for clinical AR or BHR diagnosis.
Material and methods: Pulmonary function tests and BHR in the exercise tests were done in 139 schoolchildren 
(8-14 years of age) with symptoms of non-infectious rhinitis. The analyzed biomarkers included exhaled nitric oxide
(FeNO), total IgE (tIgE), serum IL-4, serum tumour necrosis factor α (TNF-α), absolute eosinophils count in blood
(Eos). Positive prick tests with 10 aeroallergens identified children with AR.
Results: Spirometric parameters and values of BHR were not different in AR (n = 73) and NAR (n = 66) groups. The
risk of BHR was higher in children with AR than those with NAR (OR = 2.768; p = 0.051). In the logistic regression
analysis, none of the analyzed biomarkers was related to BHR. Differences in the area under the ROC curve (AUC)
for: tIgE and FeNO (AUCtIgE-AUCFeNO = 0.102; p = 0.042), FeNO and Eos (AUCFeNO-AUCEos = 0.07; p = 0.219), 
tIgE and Eos (AUCtIgE-AUCEos = 0.172; p = 0.002) showed that measurements of tIgE level were the best diagnostic
tool for AR (sensitivity = 78.9%, specificity = 79.4% for tIgE = 68 kU/l). 
Conclusions: There were no differences in pulmonary function test parameters between groups of children with AR
and NAR. Bronchial hyperresponsiveness was more often observed in AR than in NAR. Any biomarker of allergic
inflammation predicts BHR in children with rhinitis. The accuracy of diagnostic AR testing with tIgE measurement
(cut-off level = 68 kU/l) was moderately good in schoolchildren.
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Introduction
In the last decades, an increased prevalence of aller-
gic diseases in children has been observed, including aller-
gic rhinitis. Moreover, accumulation of clinical and epi-
demiological data indicates that incidence of chronic
rhinitis without any allergic background has been also
increasing [1, 2]. Nowadays, non-infectious rhinitis could
be classified into the following groups: 1) allergic rhinitis
(AR) – where IgE-mediated mechanisms are involved (pos-
itive skin prick tests, increased specific IgE in the serum
to the specified allergens); 2) nonallergic rhinitis (NAR) –
the systemic IgE-related mechanisms is not possible to
determine as it can be done in AR. However, there are
increasing experimental data indicating that local aller-
gic inflammation restricted to nasal mucosa could be
shown [3]; 3) rhinosinusitis – a clinical situation, in which
an infectious agent causes a chronic inflammatory process
of the nose and the paranasal sinuses [4, 5]; 4) other
uncommon conditions, especially in children, related to
exposure to noxious agents, some non-steroid anti-inflam-
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matory drugs, structural abnormalities of the nasopha-
ryngeal cavity or systemic diseases (immunodeficiency,
cystic fibrosis, primary cilia dyskinesia and others) [6].
Presently, there are no laboratory tests to confirm that
a patient suffers from NAR, and this condition is defined
by exclusion, i.e. absence of the allergen specific IgE anti-
bodies and absence of the active infectious process. Recog-
nition of limited knowledge in the NAR area has con-
tributed to further research perspectives of clinical and
epidemiological studies, which was formulated by GA2LEN
(Global Allergy and Asthma European Network) [1].
Aim
The aim of the present study, complementary to pre-
vious one [7], was to characterize and compare the pul-
monary function tests and some biomarkers of allergic
inflammatory processes in schoolchildren with AR and NAR
and to determine which of these parameters would be the
most suitable for differentiation and clinical diagnosis of
these two types of rhinitis.
Material and methods
Study population
Children were enrolled to the study through the Aller-
gy Preventive Program held in Krakow, implemented by
the Outpatient Department of Pulmonology and Allergy
of the Polish-American Children's Hospital. Invitations to
the program were distributed by local media. After a short
phone survey of parents, children who fulfilled inclusion
criteria were invited to visit the outpatient department.
During the first study visit, pre-enrollment conditions
obtained by phone were confirmed and a more precise
interview was carried out. The following inclusion crite-
ria were employed: 1) 8-14 years of age; 2) living within
the city limits of Krakow; 3) chronic, permanent nasal
symptoms in the last year. The exclusion criteria were: 
1) treatment with antihistaminic medicines in the last 
4 weeks; 2) treatment with nasal aerosols in the last 
4 weeks; 3) treatment with antiasthmatic medicines
(inhaled or systemic) in the last 4 weeks; 4) established
diagnosis and treatment of AR in the past; 5) signs of rhi-
nosinusitis in the past and/or during the present visit
(anterior rhinoscopic examinations were done); 6) estab-
lished diagnosis of asthma or other chronic respiratory
tract disorders or other systemic diseases; 7) acute infec-
tion of the respiratory system in the last 4 weeks. The vis-
its were scheduled for September and October.
The study was approved by the Bioethical Committee
of Jagiellonian University. All the parents and children above
12 years of age gave their written informed consent.
Clinical questionnaire-based interviews
Presentation and qualification of clinical symptoms
were identified with a modified ISAAC questionnaire for
Phase II of that study. The questionnaires were filled out
by children and their parents under the investigator's
supervision. In the module of nasal symptoms, questions
asked concerned the type of nasal symptoms apart from
a cold or the flu in the last year (verification of answers
obtained during phone questioning), their duration (above
4 weeks and longer than 4 days in a week) for rhinitis clas-
sification purposes (intermittent, persistent) according to
the ARIA (Allergic Rhinitis and its Impact on Asthma)
guidelines [6]. 
Skin prick tests
Sensitization was assessed by skin prick tests (SPT)
performed in a typical manner, using the following 10 aller-
gens (Allergopharma, Germany): indoor allergens – house
dust mites (D. pteronyssimus, D. farine), dog, cat, molds
(Alternaria, Aspergillus, Cladosporium), outdoor allergens
– grasses, trees, weeds. The reaction to each of the aller-
gens was regarded positive if the mean wheal diameter
was at least 3 mm. Atopy was defined as a positive SPT
to at least one of the aeroallergens.
Definitions of diagnosis
Allergic rhinitis was diagnosed if atopy and nasal
symptoms (sneezing, itching, rhinorhea, nasal obstruc-
tion) were present, apart from viral infections, in the last
year. Nonallergic rhinitis was diagnosed if the condition
of rhinitis was fulfilled, but atopy was not present.
According to the ARIA classification, chronic rhinitis
was established when duration of rhinitis was more than
4 days per week and longer than 4 weeks in the last year.
Intermittent rhinitis was diagnosed when duration of
symptoms did not fulfill conditions of chronic rhinitis.
Lung function tests
The lung function tests were performed with the
spirometer – Lungtest 1000 (MES, Kraków, Poland) accord-
ing to ERS/ATS [8] standards. Three acceptable forced
exhalation attempts, lasting more than 3 s, with distin-
guished flow plateau at the end of exhalation allowed for
choosing the best parameters: FEV1, FVC, FEF25-75%,
FEV1/FVC and computing the percentage of the predict-
ed value using the equations provided in the spirometer
software [9]. The value of FEV1 below 80% of the predict-
ed value was an indication to perform the bronchodila-
tor-response tests with 200 μg of salbutamol given by
spacer. A relative increase of FEV1 above 12% and an
absolute increase of more than 200 ml indicated positiv-
ity of the test.
Bronchial hyperresponsiveness
The exercise challenge test was done in concordance
with published guidelines for bronchial hyperresponsive-
ness (BHR) estimation [10]. In brief, all the children per-
formed baseline spirometry before the challenge test. Dur-
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ing the test, the heart rate and SpO2 were monitored with
a pulse oxymeter. Adequate child cooperation and its FEV1
above 80% of the predicted value were the conditions for
qualification to the challenge test. The exercise test was
performed using a treadmill and the effort was increased
by the slope and speed during 6 min of running and
adjusted to obtain 80-90% of the maximal predicted heart
rate (calculated as 220 – age in years) in the last 4 min of
the test. Appropriate conditions of ventilation were 
maintained by a nose clip, room air temperature of 
19-22°C and relative air humidity below 55%. Spirometry
with FEV1 measurement was performed 1, 5, 10, 15 and 
20 min after exercising. Bronchial hyperresponsiveness
was recognized when a relative decrease of FEV1 after the
test was no less than 10% (ΔFEV1 ≥ 10%). The children hav-
ing baseline FEV1 below 80% and positive bronchodilator-
response test after salbutamol were regarded as these
with BHR and the value ΔFEV1 of 25% was arbitrarily des-
ignated for them for further statistical analyses. 
Biomarkers of allergic process
The following biomarkers were selected for identifi-
cation of allergic inflammation: exhaled nitric oxide
(FeNO), serum total IgE (tIgE), absolute eosinophils count
of the peripheral blood (Eos), serum interleukin 4 (IL-4)
and tumour necrosis factor α (TNF-α).
Measurement of exhaled nitric oxide (FeNO) were per-
formed with NIOX MINO® (Airway Inflammation Monitor
(NIOX MINO); Aerocrine AB, Solna, Sweden) following inter-
national guidelines and the manufacturer's instructions,
maintaining 50 ±5 ml/s air flow during exhalation [11].
The levels of tIgE were measured using the immuno-
fluorometric method (ImmunoCAP, Phadia AB, Sweden)
with the assay sensitivity range of 2-5000 kU/l. Serum
levels of IL-4 and TNF-α were estimated by ELISA with
Quantikine®HS kits (R&D Systems, Inc., USA) following
the manufacturer’s instructions and with the sensitivity
measurements of 0.03-0.22 pg/ml and 0.038-0.191 pg/ml,
respectively. The absolute eosinophils counts were calcu-
lated according to standard hospital laboratory methods.
Statistical analysis
Differences in continuous data were estimated with
the parametric tests with or without logarithmic trans-
formation of variables and presented as geometric or
arithmetic means with 95% confidence interval (95% CI)
or standard deviation (SD), as appropriate. In the case of
rejection of normality distribution after logarithmic trans-
formation, the Mann-Whitney test was used and differ-
ences between data were displayed by the median value
of the variable with 95% CI. The relationship of categori-
cal data was estimated by the χ2 test and in the case of
significance level of this test, the odds ratio (OR) with 
95% CI was calculated. The ROC (Receiver Operating Char-
acteristic) curves were used to determine accuracy of dif-
ferent biomarkers as the diagnostic tests with the esti-
mation of difference significance of the area under curves
(AUC) larger than 0.5 in z-statistics. Logistic regression
with stepwise option was chosen to find out which para-
meter was related to BHR. 
A p-value ≤ 0.05 was considered statistically signifi-
cant. Statistical analysis was performed using the Med-
Calc® version 10.0.1.0. software. 
Results
During 3 months of phone recruitment to the study,
155 children were qualified and 149 of them were seen in
the outpatient department. After subsequent question-
ing, 141 subjects fulfilled the inclusion criteria.
Correct spirometric tests were done by 139 children;
in this group 110 presented with chronic rhinitis (61 with
AR and 49 with NAR), 29 – with intermittent rhinitis 
(12 with AR and 17 with NAR).
Chronic rhinitis
There were no differences in the predicted values of
FEV1, FEV1/FVC between children with AR and NAR in the
group of chronic rhinitis. However, the values of FEF25-75%
were lower in the NAR group than in the AR group (dif-
ference of borderline significance (p = 0.084) (Table 1).
Bronchial hyperresponsiveness in the group with
chronic rhinitis was seen in 12% (6/49) of subjects with
NAR and in 28% (17/61) of subjects with AR (borderline
significance in the difference; p = 0.077). The calculated
odds ratio for BHR in AR in comparison to NAR was 2.768
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Table 1. Spirometric parameters (% of predicted values,
mean ± SD) in children with allergic rhinitis (AR) and nonal-
lergic rhinitis (NAR) in chronic and intermittent rhinitis
AR NAR Value of p
Chronic rhinitis n = 61 n = 49
FEV1 100.8 ±12.9 102.7 ±11.1 0.433
FEF25-75% 106.0 ±25.4 98.2 ±20.5 0.084
FEV1/FVC* 93.2 92.3 0.510
(91.2-94.4) (87.2-95.0)
ΔFEV1* 5.9 4.1 0.072
(4.8-8.0) (2.5-5.7)
Intermittent rhinitis n = 12 n = 17
FEV1 105.4 ±14.0 93.5 ±10.5 0.014
FEF25-75% 99.8 ±18.5 89.7 ±19.9 0.177
FEV1/FVC* 91.0 90.2 0.642
(81.4-96.8) (82.3-95.5)
ΔFEV1* 2.9 4.6 0.425
(–0.6-11.4) (0.6-11.9)
ΔFEV1 – relative drop of FEV1 in the exercise challenge test, *median (95% 
confidence interval for median)
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with 95% CI (0.997-7.688) (p = 0.051). Moreover, the val-
ues of ΔFEV1 in the NAR group were slightly lower as com-
pared to these in the AR group (p = 0.072) (Table 1). 
Of note, in two subjects with AR and in one with NAR, the
bronchodilator-response tests were done because their
baseline FEV1 values were less than 80% of the predict-
ed values.
Intermittent rhinitis
Of all the analyzed spirometric parameters, only the
mean value of FEV1 was significantly lower in children
with intermittent NAR in comparison to AR (p = 0.014)
(Table 1). Bronchial hyperresponsiveness was observed in
5 children out of 17 (29%) with NAR and in two out of 12
(17%) with AR (p = 0.73). There were no significant 
differences in ΔFEV1 in both groups (Table 1). In one child
from the NAR group, the bronchodilator-response 
test was done (his baseline FEV1 < 80% of the predicted
value).
Biomarkers of allergic inflammation
The characteristics and observed differences in the
analyzed inflammatory biomarkers (tIgE, FeNO, IL-4, 
TNF-α, Eos) are presented in Table 2.
Accuracy of the allergic biomarkers in the diagnosis
of AR in children with chronic or intermittent rhinitis
The parameters of the test accuracy for AR diagno-
sis with different biomarkers of allergic inflammations
with the best cut-off level are displayed in Table 2. The
results are shown together for chronic and intermittent
rhinitis, because of a relatively small number of subjects
in the intermittent group and no differences in diag-
nostic accuracy of the analyzed biomarker separately
for chronic and intermittent rhinitis groups (results not
shown).
The analysis of differences in AUC for tIgE and FeNO
(AUCtIgE-AUCFeNO = 0.102; p = 0.042), FeNO and Eos
(AUCFeNO-AUCEos = 0.07; p = 0.219), tIgE and Eos (AUCtIgE-
AUCEos = 0.172; p = 0.002) demonstrated that the tIgE
level was the test which in the best way differentiated
between AR and NAR. The same conclusion can be drawn
from the test accuracy parameters shown in Table 2 and
from a graphical analysis of the position of appropriate
ROC curves (Figure 1).
Relationship of allergic inflammation biomarkers with
bronchial hyperresponsiveness
Logistic regression analysis did not include any ana-
lyzed biomarkers as a prediction factor of BHR in children
with AR or NAR in the entire rhinitis group (chronic and
intermittent).
Discussion
Despite the very similar prevalence of AR and NAR in
children, the clinical characteristics and course of NAR are
not fully understood [12]. Nowadays, the associations
Table 2. Biomarkers of allergic inflammation (geometric mean
and 95% CI) in children with allergic rhinitis (AR) and nonal-
lergic rhinitis (NAR) in chronic and intermittent rhinitis 
AR NAR Value of p
Chronic rhinitis n = 61 n = 49
FeNO [ppb] 23.5 12.7 < 0.0001
(19.3-28.7) (10.9-14.7)
tIgE [kU/l] 181.3 33.6 < 0.0001
(125.8-261.3) (23.9-47.3)
IL-4 [pg/ml] 0.182 0.182 0.913
(0.177-0.187) (0.173-0.192)
TNF-α [pg/ml] 1.134 1.277 0.113
(1.058-1.215) (1.086-1.502)
Eos [cells/μl]* 238 126 0.002
(181.7-294.3) (67.9-175.3)
Intermittent rhinitis n = 12 n = 17
FeNO [ppb] 23.3 11.7 0.034
(12.6-43.0) (9.7-13.9)
tIgE [kU/l] 223.9 30.4 0.003
(114.4-438.6) (10.4-88.3)
IL-4 [pg/ml] 0.18 0.17 0.859
(0.17-0.18) (0.16-0.19)
TNF-α [pg/ml] 1.19 1.13 0.708
(1.04-1.35) (0.83-1.55)
Eos [cells/μl]* 160 171 0.807
(56.5-307.3) (39.0-273.8)
*Median (95% CI for median), 95% CI – 95% confidence interval
Table 3. Tests accuracy for diagnosis of allergic rhinitis with different biomarkers of allergic inflammation 
Biomarker Cut-off level Sensitivity Specificity (+)PV (–)PV AUC 95% CI Value of p
for AUC for AUC > 0.5
tIgE 68 kU/l 78.9 79.4 81.2 76.9 0.829 0.755-0.889 0.0001
FeNO 19.6 ppb 57.3 86.8 82.7 64.8 0.738 0.658-0.808 0.0001
Eos 150 cells/μl 70.3 60.9 67.5 63.9 0.661 0.576-0.740 0.0004
(+)PV – positive predictive value, (–)PV – negative predictive value, AUC – area under ROC curve, 95% CI – 95% confidence interval
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between AR and other allergic diseases, especially asth-
ma, are very well known and established. This close inter-
relationship between asthma and AR has been expressed
in the concept of united airways for the several years 
[6, 13]. Much less is known about the effect of chronic in -
flammatory process on the respiratory system in NAR [1].
In this study, we aimed at characterizing the pul-
monary function parameters in the group of children with
NAR in relation to AR. Moreover, we tried to find the mark-
er (except allergy testing) which would best differentiate
these two rhinitic conditions. We believe that a positive
side of this study is the way the children were recruited,
which resembles the cohort of pediatric patients visiting
outpatient departments because of chronic rhinitis.
The evaluation of spirometric parameters (FEV1, 
FEF25-75%, FVC, FEV1/FVC) did not demonstrate essential
differences between groups of schoolchildren with NAR
and AR. The observed significantly lower values of FEV1
with intermittent rhinitis in NAR as compared to the AR
group should be interpreted with caution because of a low
number of analyzed subjects. In the present literature,
there are no data available on the comparison of base-
line spirometric parameters in children with AR and NAR.
However, in adults and adolescents, Molgaard et al. did
not show differences in spirometric values (FEV1, FVC,
FEV1/FVC) in AR and NAR groups [14]. However, in their
study, the authors indicated that nasal symptoms in NAR
were more prominent and lasted longer than in AR.
Besides, BHR in that study was less common in the NAR
group [14].
The same situation was observed in the present study.
The prevalence of bronchoconstrictor response after exer-
cise was over 2.5 times higher (OR = 2.8) in AR than in NAR.
On the other hand, a relative decrease of FEV1 in the exer-
cise challenge test in children was no different between
the NAR and AR groups. A much greater difference in the
prevalence of post exercise bronchoconstrictor response
in children with chronic rhinitis was observed by Bronstein
and Atlas. In their study, this response was noted in almost
half of children (47.2%) with AR and 5% with NAR [15]. The
difference between this study and Bronstein’s investiga-
tions could be explained by changes in the epidemiologi-
cal situation of chronic rhinitis (the study by Bronstein was
done 20 years ago) and better standardization of the exer-
cise challenge test at the present time [10]. Recently, in the
published study in adults, metacholin-induced BHR was
shown in 35% of subjects with AR and in 20% with NAR
[14]. Another study indicated no difference in asthma and
BHR prevalence in adults with AR and NAR [16]. Moreover,
a large European study showed that chronic rhinitis (aller-
gic and nonallergic) was an independent risk factor for
BHR and asthma in adults [17]. It was demonstrated that
there was a better relationship of asthma or rhinosinusi-
tis with AR than with NAR [18] and the risk of asthma was
almost 8 times higher in AR adult subjects in comparison
to the normal population [19].
Allergic rhinitis is characterized by polarization of
immunological response towards Th2 lymphocytes. The
involvement of cytokines, especially interleukin (IL)-4 and
IL-5, was evaluated in the previous studies with the sea-
sonal AR [20]. Interleukin-4 is a cytokine, which induces
skewness into Th2 cells, stimulates the synthesis of IgE
and adhesive molecules, which in turn increases recruit-
ment of eosinophils into an allergic inflammation site and
production of mucus. It could be suspected that this
cytokine plays one of the main roles in propagation of the
inflammatory process in AR [21]. The role of another
cytokine – TNF-α – in the pathology of allergic inflam-
mation is not completely determined. It is synthesized
together with IL-1, IL-6, IL-8 by fibroblasts, endothelial and
epithelial cells and macrophages under influence of IL-17
released by the specific subpopulation of lymphocytes
[22]. Participation of TNF-α in maintaining allergic inflam-
matory process was demonstrated in several clinical stud-
ies [23-26].
Taking together the above data, in this study we com-
pared the levels of IL-4 and TNF-α with other known aller-
gy inflammation markers (e.g. FeNO, tIgE, eosinophilia lev-
el) in the AR and NAR groups of children. Moreover, we
estimated the value of these markers in the differentia-
tion of AR and NAR. 
This study showed significantly higher levels of FeNO,
tIgE and absolute eosinophils in chronic AR and FeNO, tIgE
in intermittent AR in comparison to NAR. The difference
in absolute levels of eosinophils was not more significant
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Fig. 1. ROC curve for comparison of diagnostic accuracy of
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in intermittent rhinitis. Moreover, the levels of cytokines
IL-4 and TNF-αwere not suitable for differentiation of chil-
dren with AR or NAR. The differences in the levels of the
determined biomarkers (FeNO, tIgE, absolute eosinophils)
supported an analysis aiming at establishing which of
them would be the best predictor for AR diagnosis. The
comparison of ROC curves showed that measurement of
tIgE was the test with the best accuracy. The 68 kU/l cut-
off level gave approximately 80% of the sensitivity and
specificity. In comparison, FeNO level of approximately 
20 ppb gave sensitivity slightly above 60% and specificity
of approximately 87%. None of the analyzed markers was
significantly related to BHR in children with AR or NAR. 
These results of our study are in concordance with
studies in adults. Rolla et al. showed significantly higher
FeNO levels in subjects with AR than in NAR; moreover,
higher values were seen in these patients with asthma
[18]. The evidence of the usefulness of FeNO measurement
in AR was presented in the study by Henriksen et al. 
The level of this biomarker was higher during seasonal
aeroallergens exposure [27]. However, there were no cor-
relations between FeNO and parameters of pulmonary
function tests in subjects with AR [28].
Moreover, there was no relationship between FeNO
and BHR in children with asthma in other studies [29].
Rondon et al. demonstrated significant differences in
tIgE levels between AR and NAR in adults, but without any
differences between NAR and healthy subjects. In that
study, serum ECP levels (analysis of eosinophils was not
presented) were not different between the observed
groups [30]. In the previous studies in children, differences
were shown in peripheral eosinophils and ECP in serum
related to diagnosis of AR or NAR, but only the ECP level
correlated with nasal symptoms score [31]. In another
study, significantly higher levels of tIgE, ECP and FeNO
were observed in children with AR in relation to healthy
children without atopy. The interesting finding of that
study was that there was no effect of intranasal antial-
lergic treatment on FeNO levels with a concurrent
decrease of ECP levels during this therapy [32]. 
In this study, we have demonstrated a relatively good
discrimination value of serum tIgE levels for differentia-
tion between AR and NAR and a moderate value for FeNO
measurements. These observations are in agreement with
the results of other authors, who established the useful-
ness of tIgE for the allergic diseases diagnosis. Moreover,
a significant positive correlation between tIgE and FeNO
in the group of children with AR was seen, being even bet-
ter with the number of positive prick tests [33].
Conclusions
The comparison of groups of children with AR and NAR
demonstrated no significant differences in their pul-
monary function tests. The frequency of BHR estimated
in the exercise challenge test was higher in the AR group
than in the NAR group. None of the analyzed markers of
allergic inflammation (FeNO, IL-4, TNF-α, tIgE, eosinophil-
ia) was significantly related to BHR in children with rhini-
tis. However, the level 68 kU/l of tIgE was a marker, which
with moderate accuracy diagnoses AR in schoolchildren.
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